Table 5.
Adjusted mean PGWB total score by complete heartburn resolution status
| Trial/Follow-up | Resolution Status | n | Mean (s.e.) |
| Clinical Trial 1 | |||
| 8 Weeks | Completely resolved | 97 | 84.2 (1.5)* |
| Not resolved | 193 | 80.9 (1.2) | |
| Clinical Trial 2 | |||
| 4 Weeks | Completely resolved | 263 | 83.7 (0.9)* |
| Not resolved | 386 | 80.8 (0.8) | |
| 8 Weeks | Completely resolved | 257 | 84.3 (1.0)* |
| Not resolved | 386 | 81.4 (0.9) | |
| 12 Weeks | Completely resolved | 250 | 85.5 (1.0)* |
| Not resolved | 383 | 82.4 (0.9) | |
| 16 Weeks | Completely resolved | 235 | 90.0 (1.1)* |
| Not resolved | 390 | 82.9 (0.9) | |
| Clinical Trial 3 | |||
| 4 Weeks | Completely resolved | 116 | 77.5 (1.8)* |
| Not resolved | 108 | 69.2 (1.9) | |
| 12 Weeks | Completely resolved | 73 | 76.2 (2.3)* |
| Not resolved | 121 | 67.4 (2.0) | |
| 24 Weeks | Completely resolved | 72 | 78.6 (2.5)* |
| Not resolved | 125 | 63.3 (2.1) |
*p < 0.05 for test of overall differences in least square means from ANCOVA model, adjusted for gender, age, relevant baseline PGWB total score, and baseline severity.